Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
NCT00551759 is a phase 2 interventional trial sponsored by Eastern Cooperative Oncology Group. As of 21 Nov 2026, it was terminated. It studies Fluorouracil, Cetuximab, Docetaxel and Oxaliplatin in Esophageal Cancer. The registry lists an enrollment of 22 participants at 109 sites in 1 country. The registry lists a start date of 2 Oct 2008 and a primary completion date of 31 Oct 2011.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00551759 |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional trial |
| Lead sponsor | Eastern Cooperative Oncology Group |
| Enrollment | 22 |
| Registered sites | 109 |
| Countries | 1 |
| Conditions | Esophageal Cancer |
| Drugs | Fluorouracil, Cetuximab, Docetaxel and Oxaliplatin |
| Start | 2 Oct 2008 |
| Primary completion | 31 Oct 2011 |
| Study completion | 28 Feb 2014 |
| Last update posted | 3 Jul 2023 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Michael K. Gibson, MD
University of Pittsburgh
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
109 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tunnell Cancer Center at Beebe Medical Center
Lewes
- Ccop - Christiana Care Health Services
Newark
- Rush-Copley Cancer Care Center
Aurora
- Hematology and Oncology Associates
Chicago
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago
- Decatur Memorial Hospital Cancer Care Institute
Decatur
- Hinsdale Hematology Oncology Associates
Hinsdale
- Joliet Oncology-Hematology Associates, Limited - West
Joliet
- Midwest Center for Hematology/oncology
Joliet
- North Shore Oncology and Hematology Associates, Limited - Libertyville
Libertyville
- la Grange Oncology Associates - Geneva
Naperville
- Cancer Care and Hematology Specialists of Chicagoland - Niles
Niles
- Swedish-American Regional Cancer Center
Rockford
- Hematology Oncology Associates - Skokie
Skokie
- Regional Cancer Center at Memorial Medical Center
Springfield
- Ccop - Carle Cancer Center
Urbana
- Carle Cancer Center at Carle Foundation Hospital
Urbana
- Saint Anthony Memorial Health Centers
Michigan City
- Mcfarland Clinic, Pc
Ames
- Cedar Rapids Oncology Associates
Cedar Rapids
- Ccop - Iowa Oncology Research Association
Des Moines
- John Stoddard Cancer Center at Iowa Lutheran Hospital
Des Moines
- John Stoddard Cancer Center at Iowa Methodist Medical Center
Des Moines
- Medical Oncology and Hematology Associates at John Stoddard Cancer Center
Des Moines
- Medical Oncology and Hematology Associates at Mercy Cancer Center
Des Moines
- Mercy Cancer Center at Mercy Medical Center - Des Moines
Des Moines
- Mercy Capitol Hospital
Des Moines
- Mercy Cancer Center at Mercy Medical Center - North Iowa
Mason City
- Mccreery Cancer Center at Ottumwa Regional
Ottumwa
- Mercy Medical Center - Sioux City
Sioux City
- Siouxland Hematology-Oncology Associates, Llp
Sioux City
- St. Luke's Regional Medical Center
Sioux City
- Cancer Center of Kansas, Pa - Chanute
Chanute
- Cancer Center of Kansas, Pa - Dodge City
Dodge City
- Cancer Center of Kansas, Pa - El Dorado
El Dorado
- Cancer Center of Kansas-Independence
Independence
- Cancer Center of Kansas, Pa - Kingman
Kingman
- Lawrence Memorial Hospital
Lawrence
- Southwest Medical Center
Liberal
- Cancer Center of Kansas, Pa - Newton
Newton
- Cancer Center of Kansas, Pa - Parsons
Parsons
- Cancer Center of Kansas, Pa - Pratt
Pratt
- Cancer Center of Kansas, Pa - Salina
Salina
- Cancer Center of Kansas, Pa - Wellington
Wellington
- Associates in Womens Health, Pa - North Review
Wichita
- Ccop - Wichita
Wichita
- Cancer Center of Kansas, Pa - Medical Arts Tower
Wichita
- Cancer Center of Kansas, Pa - Wichita
Wichita
- Via Christi Cancer Center at Via Christi Regional Medical Center
Wichita
- Wesley Medical Center
Wichita
- Cancer Center of Kansas, Pa - Winfield
Winfield
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore
- Union Hospital Cancer Program at Union Hospital
Elkton
- Beth Israel Deaconess Medical Center
Boston
- Borgess Medical Center
Kalamazoo
- Bronson Methodist Hospital
Kalamazoo
- West Michigan Cancer Center
Kalamazoo
- Fairview Ridges Hospital
Burnsville
- Mercy and Unity Cancer Center at Mercy Hospital
Coon Rapids
- Fairview Southdale Hospital
Edina
- Mercy and Unity Cancer Center at Unity Hospital
Fridley
- Minnesota Oncology Hematology, Pa - Maplewood
Maplewood
- Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
Minneapolis
- Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center
Robbinsdale
- Ccop - Metro-Minnesota
Saint Louis Park
- Park Nicollet Cancer Center
Saint Louis Park
- United Hospital
Saint Paul
- St. Francis Cancer Center at St. Francis Medical Center
Shakopee
- Ridgeview Medical Center
Waconia
- Minnesota Oncology Hematology, Pa - Woodbury
Woodbury
- Cancer Resource Center - Lincoln
Lincoln
- Alegant Health Cancer Center at Bergan Mercy Medical Center
Omaha
- Ccop - Missouri Valley Cancer Consortium
Omaha
- Creighton University Medical Center
Omaha
- Immanuel Medical Center
Omaha
- Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton
Marlton
- Carol G. Simon Cancer Center at Morristown Memorial Hospital
Morristown
- Overlook Hospital
Summit
- Cancer Institute of New Jersey at Cooper - Voorhees
Voorhees Township
- Fox Chase Virtua Health Cancer Program at Virtua West Jersey
Voorhees Township
- Our Lady of Mercy Medical Center Comprehensive Cancer Center
The Bronx
- Summa Center for Cancer Care at Akron City Hospital
Akron
- Aultman Cancer Center at Aultman Hospital
Canton
- Mercy Cancer Center at Mercy Medical Center
Canton
- St. Luke's Cancer Network at St. Luke's Hospital
Bethlehem
- Bryn Mawr Hospital
Bryn Mawr
- Cancer Center of Paoli Memorial Hospital
Paoli
- Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Philadelphia
- Upmc Cancer Centers
Pittsburgh
- Pottstown Memorial Regional Cancer Center
Pottstown
- Mcglinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading
- Hematology and Oncology Associates of Northeastern Pennsylvania
Scranton
- Ccop - Main Line Health
Wynnewood
- Lankenau Cancer Center at Lankenau Hospital
Wynnewood
- Avera Cancer Institute
Sioux Falls
- Medical X-Ray Center, Pc
Sioux Falls
- Sanford Cancer Center at Sanford Usd Medical Center
Sioux Falls
- Center for Cancer Treatment & Prevention at Sacred Heart Hospital
Eau Claire
- Marshfield Clinic Cancer Care at Regional Cancer Center
Eau Claire
- Gundersen Lutheran Center for Cancer and Blood
La Crosse
- Marshfield Clinic - Marshfield Center
Marshfield
- Saint Joseph's Hospital
Marshfield
- Marshfield Clinic - Lakeland Center
Minocqua
- Ministry Medical Group at Saint Mary's Hospital
Rhinelander
- Marshfield Clinic - Indianhead Center
Rice Lake
- Saint Michael's Hospital Cancer Center
Stevens Point
- Marshfield Clinic - Wausau Center
Wausau
- Marshfield Clinic - Weston Center
Weston
- Marshfield Clinic - Wisconsin Rapids Center
Wisconsin Rapids
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT00551759
Each answer restates registry values shown on this page.
What is NCT00551759?
NCT00551759 is a phase 2 interventional trial sponsored by Eastern Cooperative Oncology Group. It studies Fluorouracil, Cetuximab, Docetaxel and Oxaliplatin in Esophageal Cancer.
Who leads NCT00551759?
The registry names Michael K. Gibson, MD (study chair, University of Pittsburgh) as the overall official.
Where does NCT00551759 run?
The registry lists 109 sites in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT00551759 study?
The registered drug and biological interventions are Fluorouracil, Cetuximab, Docetaxel and Oxaliplatin.
When did NCT00551759 end?
The registry lists a primary completion date of 31 Oct 2011 and a study completion date of 28 Feb 2014. The sponsor last updated the record on 3 Jul 2023.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.